Antibiotic Resistance in Pediatric Pneumonia Patients: Assessing Prevalence and Prescribing Practices
DOI:
https://doi.org/10.53560/PPASB(61-sp1)1012Keywords:
Antimicrobial Resistance (AMR), Antibiotic Responsiveness, Amoxicillin-cloxacillin, Pediatric PneumoniaAbstract
Antimicrobial resistance (AMR) has become a significant worldwide health issue, endangering public health through diminished opportunities for treatments, an increasing incidence of morbidity and mortality, and increasing healthcare costs. This study investigates the prevalence of antibiotic resistance, prescribing patterns and antibiotic responsiveness in pediatric pneumonia with an effort to highlight the urgent need to address this issue. This study assessed the antibiotic prescriptions, hospital longevity and treatment outcomes in 73 pneumonia patients. A total of 506 drugs were prescribed, with an average of 6.9 drugs per prescription, surpassing the recommended WHO standard of 1.6-1.8 drugs. Antibiotics accounted for 38.7% of the prescribed drugs (n=197). Injectable drugs, generic names, and drugs from the Essential Drug List (EDL) comprised 58.5%, 12.84%, and 95% of the prescriptions, respectively. The most common antibiotic combination was ampicillin-cloxacillin, prescribed to 33% of the patients, of which 84.5% of patients did not responded and switched to another drug combination. Ampicillin-cloxacillin-ceftazidime combination was prescribed to 14.6% of patients, however this combination received a non-response rate of 7.1%. Patients unresponsive to these regimens were switched to more efficacious antibiotics such as linezolid, vancomycin, amikacin, ceftriaxone, and cefotaxime. This study highlights the rapid emergence of antibiotic resistance in children with pneumonia, which is associated with their vulnerability to infections due to a compromised immune system. Empirical antibiotic therapy practices, which are frequently utilized in pediatric patients, have led to a rise in resistance to first-line antibiotics (amoxicillin-cloxacillin) used to treat pneumonia. In order to address this critical issue, collaborative efforts from healthcare professionals, policymakers, and the community will be required to raise awareness and promote appropriate antibiotic usage and combat the emergence of AMR in Pakistan.
References
G.A. Tramper-Stranders. Childhood community-acquired pneumonia: a review of etiology-and antimicrobial treatment studies. Paediatric Respiratory Reviews 26: 41-48 (2018).
R.S. Gereige and P.M. Laufer. Pneumonia. Pediatrics in Review 34(10): 438-456 (2013).
S. Defres, C. Marwick, and D. Nathwani. MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia. European Respiratory Journal 34(6): 1470-1476 (2009).
R. Yi, L. Tang, Y. Tian, J. Liu, and Z. Wu. Identification and classification of pneumonia disease using a deep learning-based intelligent computational framework. Neural Computing and Applications 35: 14473-14486 (2023).
D. Marangu and H. J. Zar. Childhood pneumonia in low-and-middle-income countries: an update. Paediatric Respiratory Reviews 32: 3-9 (2019).
J. Gothankar, P. Doke, G. Dhumale, P. Pore, S. Lalwani, S. Quraishi, S. Murarkar, R. Patil, V. Waghachavare, R. Dhobale, K. Rasote, S. Palkar, and N. Malshe. Reported incidence and risk factors of childhood pneumonia in India: a community-based cross-sectional study. BMC Public Health 18(1): 1-11 (2018).
A. Zeeshan, Q. Abbas, A. Siddiqui, F. Khalid, and F. Jehan. Critical illness related to community acquired pneumonia, its epidemiology and outcomes in a pediatric intensive care unit of Pakistan. Pediatric Pulmonology 56(12): 3916-3923 (2021).
S. Khan, J. Iqbal, M. Tayyeb, S. Fahad, A. Ullah, and H. Khan. Prevalence of pneumonia associated with measles among infants and children hospitalized in Khyber Teaching Hospital Peshawar KPK Pakistan. Pure and Applied Biology (PAB) 10(3): 703-712 (2021).
E. Martens and A.L. Demain. The antibiotic resistance crisis with a focus on the United States. The Journal of Antibiotics 70(5): 520-526 (2017).
F.M. de-Benedictis, E. Kerem, A.B. Chang, A.A. Colin, H.J. Zar, and A. Bush. Complicated pneumonia in children. The Lancet 396(10253): 786-798 (2020).
I.F. Hung, T. Tantawichien, Y.H. Tsai, S. Patil, and R. Zotomayor. Regional epidemiology of invasive pneumococcal disease in Asian adults: epidemiology, disease burden, serotype distribution, and antimicrobial resistance patterns and prevention. International Journal of Infectious Diseases 17(6): e364-e373 (2013).
K. Hayat, M. Rosenthal, A.H. Gillani, J, Chang, W. Ji, C. Yang, M. Jiang, M. Zhao, and Y. Fang. Perspective of key healthcare professionals on antimicrobial resistance and stewardship programs: a multicenter cross-sectional study from Pakistan. Frontiers in Pharmacology 10: 1520 (2020).
P. Hawkey. Multidrug-resistant Gram-negative bacteria: a product of globalization. Journal of Hospital Infection 89(4): 241-247 (2015).
S. Nazir and M. Azim. Assessment of antibiotic self-medication practice among public in the northwestern region of Pakistan. European Journal of Hospital Pharmacy 24(4): 200-203 (2017).
E. Charani, M. McKee, R. Ahmad, M. Balasegaram, C. Bonaconsa, and G. B. Merrettet. Optimising antimicrobial use in humans–review of current evidence and an interdisciplinary consensus on key priorities for research. The Lancet Regional Health-Europe 7: 100161 (2021).
A.O. Nyabuti, F.A. Okalebo, and E.M. Guantai. Examination of WHO/INRUD core drug use indicators at public primary healthcare centers in Kisii County Kenya. Advances in Pharmacological and Pharmaceutical Sciences 2020 (2020).
N.D. Amaha, D.G. Weldemariam, N. Abdu, and E.H. Tesfamariam. Prescribing practices using WHO prescribing indicators and factors associated with antibiotic prescribing in six community pharmacies in Asmara, Eritrea: a cross-sectional study. Antimicrobial Resistance & Infection Control 8(163): 1-7 (2019).
K.M. Mishore, Y. Girma, A. Tola, A.N. Mekuria, and Y. Ayele. Evaluation of medication use pattern among patients presenting to the emergency department of hiwot fana specialized university hospital, using WHO prescribing indicators. Frontiers in Pharmacology 11(509): 1-7 (2020).
G.T. Demoz, G.G. Kasahun, K. Hagazy, G. Woldu, S. Wahdey, D.B. Tadesse, and Y.L. Niriayo. Prescribing pattern of antibiotics using WHO prescribing indicators among inpatients in Ethiopia: a need for antibiotic stewardship program. Infection and Drug Resistance 13: 2783-2794 (2020).
J.S. Lee, D.L. Giesler, W.F. Gellad, and M.J. Fine. Antibiotic therapy for adults hospitalized with community-acquired pneumonia: a systematic review. Jama 315(6): 593-602 (2016).
M. Paul, E. Carrara, P. Retamar, T. Tängdén, R. Bitterman, R.A. Bonomo, J. de Waele, G.L. Daikos, M. Akova, S. Harbarth, C. Pulcini, J. Garnacho-Montero, K. Seme, M. Tumbarello, P. C. Lindemann, S. Gandra, Y. Yu, M. Bassetti, J. W. Mouton, E. Tacconelli, and J. Rodríguez-Bañoet. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clinical Microbiology and Infection 28(4): 521-547 (2022).
H. Shah, U. Bibi, Z. Kamal, M. Esa, M. Naeem, S. Ahmad and M. Shafiqueet. Prescribing Pattern of Ampicillin and Cloxacillin: Sensitivity and Responsiveness in Pneumonia. Proceedings of the Pakistan Academy of Sciences: B. Life and Environmental Sciences 60(S): 65-75 (2023).
P. Khatavkar, W. Gulrukh, J.S. Dawane, D. Shreyas, and V. Pandit. Understanding about antibiotics and its usage in the community-A pilot study. Health 18(3): 19-25 (2023).
M.P. Martins and Y. Karataş. A pilot study on the rational use of medicines in four tertiary care hospitals through validated World Health Organization prescribing drugs indicators. Ann Ig 32(4): 368-375 (2020).
M. Atif, M.R. Sarwar, M. Azeem, M. Naz, S. Amir, and K. Nazir. Assessment of core drug use indicators using WHO/INRUD methodology at primary healthcare centers in Bahawalpur, Pakistan. BMC Health Services Research 16(1): 1-9 (2016).
J.L. Lenjisa and T.H. Fereja. A retrospective analysis of prescribing practices through WHO prescribing indicators at four selected hospitals of West Ethiopia. Journal of Bioanalysis & Biomedicine 6(2):29 (2014).
R. Shrestha and S. Prajapati. Assessment of prescription pattern and prescription error in outpatient Department at Tertiary Care District Hospital, Central Nepal. Journal of Pharmaceutical Policy and Practice 12(1): 1-9 (2019).
A.D. Halli-Tierney, C. Scarbrough, and D. Carroll. Polypharmacy: Evaluating Risks and Deprescribing. American Family Physician. 100(1): 32-38 (2019).
M. Atif, M. Azeem, M.R . Sarwar, S. Shahid, S. Javaid, H. Ikram, U. Baig, and S. Scahillet. WHO/INRUD prescribing indicators and prescribing trends of antibiotics in the Accident and Emergency Department of Bahawal Victoria Hospital, Pakistan. Springerplus 5(1): 1-7 (2016).
A.O. Nyabuti. Core Indicators Of Appropriate Drug Use At Public Primary Healthcare Centers In Kisii County, Kenya. University of Nairobi. 2020:1-7(2020).
A. Aslam, S. Khatoon, M. Mehdi, S. Mumtaz, and B. Murtaza. Evaluation of rational drug use at teaching hospitals in Punjab, Pakistan. Journal of Pharmacy Practice and Community Medicine 2(2): 54-57 (2016).
M.S. Sarker, M.T. Amin, S. Islam, and T. Rani. Prescription pattern of antibiotics for outpatients: A cross sectional health survey conducted in three major cities of Bangladesh. IOSR Journal of Pharmacy (IOSRPHR) 10(7): 29-32 (2020).
A. Kilipamwambu, G.M. Bwire, D.T. Myemba, B.J. Njiro, and M.V. Majigo. WHO/INRUD core prescribing indicators and antibiotic utilization patterns among primary health care facilities in Ilala district, Tanzania. JAC-Antimicrobial Resistance 3(2): 1-7 (2021).
D.K. Yimenu, A. Emam, E. Elemineh, and W. Atalay. Assessment of antibiotic prescribing patterns at outpatient pharmacy using world health organization prescribing indicators. Journal of Primary Care & Community Health 10(21): 1-8 (2019).
M. Sano, Y. Shindo, K Takahashi, J. Okumura, T. Sakakibara, Y. Murakami, M. Iguchi, T. Yagi, S. Matsui, and Y. Hasegawa. Risk factors for antibiotic resistance in hospital-acquired and ventilator-associated pneumonia. Journal of Infection and Chemotherapy 28(6): 745-752 (2022).
M. Assefa and A. Amare. Biofilm-Associated multi-drug resistance in hospital-acquired infections: a review. Infection and Drug Resistance 15: 5061-5068 (2022).
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Upon acceptance of an article, its copyright will be assigned to the Pakistan Academy of Sciences.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY). Allows users to: copy the article and distribute; abstracts, create extracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation); include in a collective work (such as an anthology); and text or data mine the article. These uses are permitted even for commercial purposes, provided the user: includes a link to the license; indicates if changes were made; gives appropriate credit to the author(s) (with a link to the formal publication through the relevant DOI); and does not represent the author(s) as endorsing the adaptation of the article or modify the article in such a way as to damage the authors' honor or reputation.
